Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Aspen Pharmacare Holdings Limited · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Jun 2028 | $43.89B | $40.86B - $46.97B | $8.94B | $15.145 | 1 |
| Jun 2027 | $41.32B | $39.77B - $43.40B | $8.41B | $13.814 | 4 |
| Jun 2026 | $44.00B | $39.61B - $47.94B | $8.96B | $7.981 | 4 |
| Jun 2025 | $44.38B | $41.02B - $47.25B | $9.04B | $12.151 | 6 |
| Jun 2024 | $44.76B | $41.67B - $47.90B | $9.12B | $13.717 | 3 |
| Jun 2023 | $39.44B | $37.84B - $40.22B | $8.03B | $14.777 | 4 |
| Jun 2022 | $38.80B | $37.23B - $39.56B | $7.90B | $15.361 | 2 |
| Jun 2021 | $37.48B | $35.96B - $38.21B | $7.63B | $12.254 | 3 |
| Jun 2020 | $37.66B | $36.13B - $38.40B | $7.67B | $13.087 | 4 |
| Jun 2019 | $40.27B | $38.64B - $41.06B | $8.20B | $13.862 | 2 |
| Jun 2018 | $44.27B | $42.47B - $45.14B | $9.02B | $16.795 | 3 |
| Jun 2017 | $41.14B | $39.47B - $41.95B | $8.38B | $14.249 | 4 |